Phase II trial to evaluate efficacy and toxicity of cetuximab plus docetaxel in platinum pretreated patients with recurrent and/or metastatic head and neck cancer

被引：5
|
作者：
Knoedler, M.
Gauler, T. C.
Matzdorff, A.
Dietz, A.
Gruenwald, V.
Arnold, D.
Hennemann, B.
Schroeder, M.
Hofele, C.
Schmittel, A.
Keilholz, U.
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Univ Klinikum Essen, Essen, Germany
[3] Caritasklin, Saarbrucken, Germany
[4] Univ Klinikum Leipzig, Leipzig, Germany
[5] Hannover Med Sch, D-30623 Hannover, Germany
[6] Univ Klinikum Halle, Halle, Germany
[7] Univ Klinikum Regensburg, Regensburg, Germany
[8] St Johannes Hosp Duisburg, Duisburg, Germany
[9] Univ Klinikum Heidelberg, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6066
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Taguchi, Jun
    Shimizu, Yasushi
    Ariga, Shin
    Goda, Tomohiro
    Ohhara, Yoshihito
    Honma, Rio
    Noguchi, Takuro
    Takeuchi, Satoshi
    Kinoshita, Ichiro
    Amano, Toraji
    Mizumachi, Takatsugu
    Kano, Satoshi
    Takahara, Miki
    Abe, Takahisa
    Homma, Akihiro
    Dosaka-Akita, Hirotoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 51 - 58
  • [42] Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Jun Taguchi
    Yasushi Shimizu
    Shin Ariga
    Tomohiro Goda
    Yoshihito Ohhara
    Rio Honma
    Takuro Noguchi
    Satoshi Takeuchi
    Ichiro Kinoshita
    Toraji Amano
    Takatsugu Mizumachi
    Satoshi Kano
    Miki Takahara
    Takahisa Abe
    Akihiro Homma
    Hirotoshi Dosaka-Akita
    International Journal of Clinical Oncology, 2021, 26 : 51 - 58
  • [43] Docetaxel plus platinum combination regimen in locally advanced or metastatic head and neck cancer
    Kucukzeybek, Yuksel
    Gorumlu, Gurbuz
    Karabulut, Bulent
    Uslu, Ruchan
    Sanli, Ulus A.
    Goker, Erdem
    ANNALS OF ONCOLOGY, 2006, 17 : 187 - 187
  • [44] Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck - A phase II multicenter study
    Labourey, Jean-Luc
    Cupissol, Didier
    Calais, Gilles
    Tourani, Jean-Marc
    Kohser, Frederic
    Borel, Christian
    Eymard, Jean-Christophe
    Germann, Nathalie
    Tubiana-Mathieu, Nicole
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 278 - 282
  • [45] Interim analysis of the combination of durvalumab and cetuximab in a phase II trial of patients with recurrent and metastatic head and neck squamous cell carcinoma
    Gulati, Shuchi
    Palackdharry, Sarah
    Weatherford, Layne
    Wilson, Sarah
    Desai, Shireen
    Steele, Aubrey
    Riaz, Kashif
    Takiar, Vinita
    Draper, Trisha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [46] Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
    Haigentz, Missak, Jr.
    Kim, Mimi
    Sarta, Catherine
    Lin, Juan
    Keresztes, Roger S.
    Culliney, Bruce
    Gaba, Anu G.
    Smith, Richard V.
    Shapiro, Geoffrey I.
    Chirieac, Lucian R.
    Mariadason, John M.
    Belbin, Thomas J.
    Greally, John M.
    Wright, John J.
    Haddad, Robert I.
    ORAL ONCOLOGY, 2012, 48 (12) : 1281 - 1288
  • [47] DOCETAXEL PLUS CISPLATIN AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK CANCER
    Ohhara, Y.
    Nishimura, N.
    Nara, E.
    Nakano, K.
    Ueda, K.
    Sakajiri, S.
    Mishima, Y.
    Yokoyama, M.
    Terui, Y.
    Takahashi, S.
    Hatake, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 125 - 125
  • [48] Docetaxel and Irinotecan in Recurrent or Metastatic Head and Neck Cancer
    Argiris, Athanassios
    Buchanan, Ashley
    Brockstein, Bruce
    Kolesar, Jill
    Ghebremichael, Musie
    Pins, Michael
    Hahn, Kristine
    Axelrod, Rita
    Forastiere, Arlene
    CANCER, 2009, 115 (19) : 4504 - 4513
  • [49] Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
    Argiris, A.
    Kotsakis, A. P.
    Hoang, T.
    Worden, F. P.
    Savvides, P.
    Gibson, M. K.
    Gyanchandani, R.
    Blumenschein, G. R., Jr.
    Chen, H. X.
    Grandis, J. R.
    Harari, P. M.
    Kies, M. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 220 - 225
  • [50] PHASE-II TRIAL OF IFOSFAMIDE IN RECURRENT AND METASTATIC HEAD AND NECK-CANCER
    BUESA, JM
    FERNANDEZ, R
    ESTEBAN, E
    ESTRADA, E
    BARON, FJ
    PALACIO, I
    GRACIA, M
    LACAVE, AJ
    ANNALS OF ONCOLOGY, 1991, 2 (02) : 151 - 152
12345